Publications
2003-2007
2008 Peer Reviewed Publications and Presentations
Ford AI, Lai M, Simmons K, Persad C, Miller J, Heidebrink J, Nyquist L, Albin R, Fegan K, Giordani B. Usefulness of a telephone screening for identifying cognitive decline: Retrospective analysis of autopsy-confirmed cases of Alzheimer’s Disease. Presented at the International Neuropsychological Society Meeting, Waikoloa, HI, 2008.
Ford AI, Giordani B, Heidebrink J, Nyquist L, Persad C, Nan B, Wang C, Albin R, Fegan K. Evaluation of the usefulness of self-reported memory decline in a longitudinal study of aging and cognition. Presented at the AmericanAcademy of Neurology annual meeting, Chicago, IL 2008.
Saluja I, Turner RS: Modulation of APPswe metabolism in X11/Mint-1/APBA-1-deficient (+/-) neurons. J Neurochem, in press, 2008. Presented at the 39th Annual Meeting, American Society for Neurochemistry, San Antonio, TX, March 2008.
Turner RS, Saluja I: Alteration of hAPPswe metabolism in X11 deficient (+/-) mice. Proceedings of Keystone Symposium: Alzheimer’s Disease, in press, 2008. Presented at the Keystone Symposium on Molecular and Cellular Biology: Alzheimer’s Disease, Keystone, CO, March 2008.
2007 Peer Reviewed Publications
Connell CM, Janevic MR, Solway E., McLaughlin S. Are pets a source of support or added burden for married couples facing burden? Journal of Applied Gerontology 2007; 26; 5; 472-485.
Connell CM, Roberts JS, McLaughlin SJ. Public opinion about Alzheimer disease among Blacks, Hispanics, and Whites: Results from a national survey. Alzheimer’s Disease and Associated Disorders 2007.
Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, DeCarli CS, Turner RS, Koeppe RA, Higdon R, Minoshima S. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer’s disease. Brain 2007; 130; 10; 2616-2635.
2006 Peer Reviewed Publications
Albin R. Parkinson’s Disease: Background, Diagnosis, and Initial Management. Clinics in Geriatric Medicine 2006; 22; 4; 735-751.
Albin R. An Advance in Molecular Imaging of Dementias. The Lancet Neurology 2006; 6; 4; 288-289.
2006 Book Chapters
Turner RS: Alzheimer’s disease. In Lynch DR (ed): Neurogenetics: Scientific and Clinical Advances (Taylor and Francis, N.Y., N.Y., 2006) 643-661.
2005 Peer Reviewed Publications
Boise L & Connell CM. Diagnosing dementia – what to tell the patient and family. Geriatrics and Aging 2005, 8, 5, 48-51.
Foster NL. FDG PET in the Diagnosis of Frontotemporal Dementia. Biol Psychiatry 2005, 57: 45.
Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, Koller M. Effects of A-beta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology 2005;64:1563-1572.
Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, Heumann M, Wernette K. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing [18F]fluorodeoxyglucose and neuropsychological testing. Exp Neurol 2005;191:S95-S103.
Gilman S, Koller M, Black RS, Jenkins L, Griffith SG, Fox NC, Eisner L, Kirby L, Boada Rovira M, Forette F, Orgogozo J-M. Clinical effects of A-beta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 2005;64:1553-1562.
Harrison B, Therrien B, Giordani B. Living in the past: Alzheimer's disease behaviors from past self identities. Am J Alzheimers Dis Other Demen. 2005, 20(4): 248-54.
Kim, Scott YH, Hyungjin MK, McCallum C, Tariot PN. What do people at risk for Alzheimer disease think about surrogate consent for research? Neurology 2005, 65: 1395-1401.
Koeppe RA, Gilman S, Joshi A, Liu S, Little, R, Junck, L, Heumann M, Frey KA, Albin RL. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias. J Nucl Med 2005;46:936-944.
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ. Vitamin E and
Donepezil for the Treatment of Mild Cognitive Impairment. New England Journal of Medicine, 2005. 2379-2388.
2005 Book Chapters
Foster NL, Koeppe RE, Giordani BJ, Nichold TE, Lieberman AP. Variations of the Phenotype in Frontotemporal Dementias. In: Cummings J, Hardy J, Poncet M, Christen Y, eds. Genotype - Proteotype - Phenotype Relationships in Neurodegenerative Diseases. Series: Research and Perspectives in Alzheimer's Disease. Berlin: Spinger-Verlag, 2005:139-52
2004 Peer Reviewed Publications
Albin RL. Dominant ataxias and Friedreich ataxia: an update. Curr Opin Neurol 2003; 16(4): 507-14.
Banaszak-Holl J, Fendrick AM, Foster NL, Herzog AR, Kabeto MU, Kent DM, Straus WL, Langa KM Predicting nursing home admission: estimates from a seven year follow-up of a nationally representative sample of older Americans. Alz Dis Assoc Dis. 2004; 18: 83-89.
Connell, CM, Boise, L, Stuckey, JC, Holmes, Hudson, ML. Attitudes toward the diagnosis and disclosure of dementia among family caregivers and primary care physicians. The Gerontologist 2004; 44: 500-507.
Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, Heumann M, Wernette K. Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease. Ann Neurol 2004;55:774-780.
Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen P, Bennett DA, Foster NL, Jack C, Galasko D, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck C, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ, and the Alzheimer’s Disease Cooperative Study. Mild cognitive impairment can be distinguished from Alzheimer's disease and normal aging for clinical trials. Arch Neurol 2004;61:59-66. http://archneur.ama-assn.org/
Higdon R, Foster NL, Koeppe RA, DeCarli CS, Jagust WJ, Clark CM, et al. A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer’s disease using FDG-PET imaging. Stat Med 2004;23:315-26.
Higdon R, Foster NL, Koeppe RA, DeCarli CS, Jagust WJ, Clark CM, Barbas NR, Arnold SE, Turner RS, Heidebrink JL, Minoshima S: A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer’s disease using FDG-PET imaging. Statistics in Medicine 23: 315-326, 2004.
King GD, Cherian K, Turner RS: X11a inhibits g- but not b-cleavage of amyloid precursor protein. J Neurochem 88: 971-982, 2004.
Janevic MR, Connell CM. Exploring self-care among dementia caregivers: the role of perceived support in accomplishing exercise goals. J Women Aging 2004; 16(1-2): 71-86.
Langa KM, Larson EB, Wallace RB, Fendrick AM, Foster NL, Kabeto MU, Weir DR, Willis RJ, Herzog AR. Out-of-pocket health care expenditures among older Americans with dementia. Alzheimer Dis Assoc Disord 2004; 18: 90-98.
Langa KM, Foster NL, Larson EB. Mixed Dementia Emerging concepts and TheraputicImplications. JAMA 2004; 292: 2901-2908.
Loeffler DA, Camp DM, Schonberger MB, Singer, DJ, LeWitt, PA. Early complement activation increases in the brain in some aged normal subjects. Neurobiol. Aging, 2004; 25(8): 1001-7.
King GD, Turner RS: Adaptor protein interactions: Modulators of amyloid precursor protein metabolism and Alzheimer’s disease risk? Exp Neurol 185: 208-219, 2004.
Moretti PM, Lieberman AP, Wilde E, Giordani B, Kluin KJ, Koeppe RS, Minoshima S, Kuhl DE, Seltzer WK, Foster NL. Novel insertional presenilin 1 mutation causing AD with spastic paraparesis. Neurology 2004; 62: 1865-1868.
2004 Book Chapters
Foster NL. Neuroimaging techniques: CT, MRI, SPECT, PET. in: Richter RW, Richter BZ, eds. Alzheimer's Disease: A Physician's Guide to Practical Management. Totowa, NJ: Humana Press Inc., 2004:89-102.
Gilman S: Sporadic olivopontocerebellar atrophy and the dominantly inherited spinocerebellar ataxias. In: Smith B, Adelman G, Eds, Encyclopedia of Neuroscience, 3nd edition (Web-based). Amsterdam, Elsevier Science 2004.
Gilman S: Clinical features and treatment of cerebellar disorders. In: Watts RL, Koller WE, Eds, Movement Disorders: Neurologic Principles and Practice, 2nd Edition. New York: McGraw-Hill 2004, 723-735.
Heidebrink JL, Turner RS: Behavioral Neurology. In Labanowski M (ed): Neurology Pearls of Wisdom, 3nd ed. (Boston Medical Publishing), 2004.
2003 Peer Reviewed Publications
Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas R, Thal L, for the Alzheimer's Disease Cooperative Study. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 2003;289:2819-26.http://jama.com
Alb JG Jr, Cortese JD, Phillips SE, Albin RL, Nagy TR, Hamilton BA Bankaitis VA. Mice lacking phosphatidylinositol transfer protein alpha exhibit spinocerebellar degeneration, intestinal and hepatic steatosis, and hypoglycemia. J Biol Chem, 2003; 278:33501-33518.http://www.jbc.org/
Albin, RL. Letter to the Editor: Response to Welcome to the Genomic Era. New Eng J Med 2003;349:2170-2171. http://nejm.com
Berent, S., Giordani, B., Gilman, S., Trask, C.L., Little, R.J.A., Johanns, J.R., Kluin, K.J., Heumann, M., and Koeppe, R.A. (2003) Patterns of neuropsychological performance in multiple system atrophy compared to sporadic and hereditary olivopontocerebellar atrophy, Brain and Cognition, 50, 194-206.
Bomar JM, Benke PJ, Slattery E, Puttagunta R, Taylor L, Seong E, Nystuen A, Chen W, Albin RL, Patel PD, Kittles RA, Sheffield VC, Burmeister M. Mutations in a novel CRAL-TRIO domain encoding gene cause human Cayman Ataxia and ataxia/dystonia in the jittery mouse. Nat Genet, 2003; 35:264-269.
Connell CM, Shaw BA, Derry HA, Holmes SB, Hudson ML, Strecher VJ. Development of an Alzheimer's disease channel for the Michigan Interactive Health Kiosk Project. J Health Commun 2003;8:11-22. http://www.gwu.edu/~cih/journal/index.htm
Foster NL. New opportunities to study real-world patient management [editorial]. Scand J Gastroenterol 2003;38:341-2. Foster NL. Validating FDG-PET as a biomarker for frontotemporal dementia. Exp Neurol 2003;184 (Supplement 1):S2-S8.
Gallant MP, Connell CM. Neuroticism and depressive symptoms among spouse caregivers: do health behaviors mediate this relationship? Psychol Aging 2003;18(3):587-92.
Gilman S, Chervin R, Koeppe RA, Consens F, Little RJ, An H, Junck L, and Heumann M. Obstructive sleep apnea is related to thalamic cholinergic deficit in MSA. Neurology 2003;61: 35-39.
http://www.neurology.org/
Gilman S, Koeppe RA, Chervin R, Consens F, Little RJ, An H, Junck L, and Heumann M. REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology 2003 ;61:29-34.
http://www.neurology.org/
Grundman M, Capparelli E, Kima HT, Morris JC, Farlow M, Rubin EH, Heidebrink J, Hake A, Ho G, Schultz AN, Schafer K, Houston W, Thomas R, Thal LJ, and the Alzheimer’s Disease Cooperative Study. A multicenter, randomized, placebo controlled, multiple-dose, safety and pharmacokinetic study of AIT-082 (Neotrofin®) in mild Alzheimer’s disease patients. Life Sci 2003;73:539-53.
Haan MN. Can vitamin supplements prevent cognitive decline and dementia in old age? (editorial). 77. 2003;77:1-2.
Ingersoll-Dayton B, Schroepfer T, Pryce J, Waarala C. Enhancing relationships in nursing homes through empowerment. Soc Work 2003 ;48:420-4.
King GD, Perez RG, Steinhilb ML, Gaut JR, Turner RS: X11a modulates secretory and endocytic trafficking and processing of amyloid precursor protein: Mutational analysis of the YENPTY sequence. Neuroscience 120: 143-154, 2003.
http://www.neurology.org/
Roberts JS, Connell CM, Cisewski D, Hipps YG, Demissie S, Green RC. Differences between African-Americans and whites in their perceptions of Alzheimer's disease. Alzheimer Dis Assoc Disord 2003;17:19-26.http://www.alzheimerjournal.com
Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal LJ, for the Alzheimer’s Disease Cooperative Study. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease. Sleep 2003;26:893-901.
Turner RS. Biomarkers of Alzheimer's disease and mild cognitive impairment: are we there yet? (editorial). 183. 2003;183:7-10.
2003 Book Chapters
Foster NL. Neuropsychiatry of dementing disorders. in: Fogel BS, Schiffer RB, Rao SM. Neuropsychiatry, Second Edition. New York: Lippincott, Williams and Wilkins, 2003:1034-70.
Gallant, MP, Connell, CM. Neuroticism and depressive symptoms among spouse caregivers: Do health behaviors mediate this relationship? Psychology and Aging 2003; 18(3): 587-92.
Heidebrink JL. Neurological aspects of nondegenerative, nonvascular dementias. in: Lichtenberg PA, Murman DL, Mellow AM, eds. Handbook of Dementia: Psychological, Psychiatric, and Neurological Perspectives. Hoboken, NJ: John Wiley and Sons, 2003:197-227.
Shults C, Gilman S. Multiple system atrophy. In: Pulst SM, Ed. Genetics of Movement Disorders. San Diego: Academic Press, 2003:213-29.
Turner RS. Neurological aspects of Alzheimer's disease. in: Lichtenberg PA, Murman DL, Mellow AM, eds. Handbook of Dementia: Psychological, Psychiatric, and Neurological Perspectives. Chichester: John Wiley and Sons, 2003:1-24.
